VALLEY NATIONAL ADVISERS INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 773411
BETHLEHEM, PA
Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$680,282
-$236,841 QoQ
Shares Held
1,091
-8.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#717
of 1,297 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $1,028,190 across 22 Biotechnology names. REGN ranks #1 (66.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,091 | $680,282 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
191 | $94,875 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
161 | $86,448 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,000 | $54,540 | |
| 5 | VTVT |
vTv Therapeutics Inc.
|
980 | $36,897 | |
| 6 | MRNA |
Moderna, Inc.
|
329 | $23,039 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
200 | $16,302 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
350 | $13,653 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680,282 | 1,091 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $917,123 | 1,187 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $928,559 | 1,203 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $614,561 | 1,093 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $719,251 | 1,373 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $869,529 | 1,371 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $882,576 | 1,239 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,345,587 | 1,280 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,521,891 | 1,448 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,398,497 | 1,453 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,224,336 | 1,394 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,127,455 | 1,370 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $959,969 | 1,336 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,099,394 | 1,338 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $975,454 | 1,352 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $940,307 | 1,365 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $776,744 | 1,314 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $897,469 | 1,285 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $789,400 | 1,250 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $755,264 | 1,248 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $616,069 | 1,103 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $299,024 | 632 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $299,045 | 619 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $261,417 | 467 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $236,987 | 380 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $119,142 | 244 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||